Using oral dydrogesterone to support pregnancy in natural cycle frozen embryo transfers
Official title: A Randomized Double Blind Controlled Comparison of Oral Dydrogesterone as Luteal Phase Support in Natural Cycle Frozen-thawed Embryo Transfer
Run by The University of Hong Kong · NCT03859921 · Data updated 2026-11-12
This study is testing if taking a pill called dydrogesterone can help women under 43 who are having frozen embryo transfers have a better chance of a successful pregnancy.
Quick facts
| Phase | Phase 3 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years to 42 Years |
| Sex | Women only |
| Enrollment | 716 (estimated) |
| Sponsor | The University of Hong Kong Academic / other |
| Locations | 1 site (Hong Kong, Hong Kong) |
| Status | Recruiting |
| Started | July 1, 2021 |
| Main results expected | December 30, 2025 |
| Study ends | November 30, 2026 |
| Registry record updated | June 12, 2025 |
| Trial ID | NCT03859921 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are women under 43 years old who are undergoing frozen embryo transfer with early cleavage embryos or blastocysts.
✕Probably not a fit
Patients who require hormonal replacement cycles, use donor oocytes or embryos, or have not corrected hydrosalpinx prior to FET may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized double-blinded controlled trial aims to evaluate the effectiveness of oral dydrogesterone in increasing live birth rates during natural frozen embryo transfer (FET) cycles. Women undergoing FET at the University of Hong Kong-Queen Mary Hospital will be randomly assigned to receive either oral dydrogesterone or a placebo for two weeks following ovulation. The study will monitor the outcomes of these treatments to determine if dydrogesterone provides a significant benefit in supporting pregnancy. The trial focuses on women under 43 years of age who are undergoing FET with thawed embryos.
Why it matters
Potential benefit: If successful, this study could improve live birth rates for women undergoing natural cycle frozen embryo transfers.
How similar studies have gone: Other studies have shown promising results with similar approaches, suggesting that dydrogesterone may enhance pregnancy outcomes in assisted reproductive technologies.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age of women \<43 years at the time of stimulated IVF * Replacing early cleavage embryos or blastocysts after thawing Exclusion Criteria: * Requiring hormonal replacement cycles * Use of donor oocytes or embryos * Undergoing preimplantation genetic testing * Presence of hydrosalpinx not corrected surgically prior to FET * Refusal to join the study
Where it's running
-
Department of Obstetrics and Gynaecology
Hong Kong, Hong Kong, China Recruiting
Study contacts
- Principal investigator: Ernest HY Ng, MD — The University of Hong Kong
- Study coordinator: Ernest HY Ng, MD
- Email: nghye@hku.hk
- Phone: 852-28553400
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Daily gazpacho to improve semen quality in men with reduced sperm parameters
This study will test whether drinking a daily 330 mL serving of gazpacho for 12 weeks helps men with reduced sperm quality improve their semen parameters and lower oxidative stress.
-
New non-invasive method for selecting embryos in IVF
This study is testing a new non-invasive way to choose the best embryos during IVF to see if it can help more people get pregnant.
-
The FLORA project: looking for endometrium microbes linked to chronic endometritis and pregnancy success
This study tests the relationship between the endometrial microbiome and chronic endometritis in women undergoing IVF/ICSI.
-
Investigating the microbiome and HPV status in couples facing fertility issues
This study is looking at how the bacteria in the body and HPV might affect couples trying to get pregnant, while also testing if probiotics can improve sperm quality in men with fertility issues.
-
Using GnRH agonist for IVF and FET to improve live birth rates
This study is testing if using a GnRH agonist instead of the usual hCG trigger can help women undergoing IVF have more successful pregnancies and if it can also support women during frozen embryo transfers.
-
Test to predict pregnancy chances for IVF patients
This study is testing a new way to predict the chances of getting pregnant through IVF by looking at the vaginal bacteria in women aged 18 to 43.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.